http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2013027680-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2242 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-22 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
filingDate | 2012-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2015-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-WO2013027680-A1 |
titleOfInvention | Pharmaceutical for preventing exacerbation of malignant tumor comprising a combination of natriuretic peptide receptor GC-A agonist and GC-B agonist |
abstract | As a treatment for malignant tumors, a drug that is highly safe and can effectively treat malignant tumors, that is, at least one natriuretic peptide receptor GC-A agonist and at least one natriuretic peptide The present invention provides treatment of malignant tumors in which a receptor GC-B agonist is administered in combination, a medicament for suppressing or preventing malignant transformation, a therapeutic method by administration of the medicament, and the like. |
priorityDate | 2011-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 442.